BELITE BIO, INC (BLTE) Balance Sheet
As of 2025-12-31 (20-F), BELITE BIO, INC (BLTE) reported total assets of $780.6M, total liabilities of $10.1M and shareholders' equity of $770.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $352.9M.
Source: SEC EDGAR filings · read by EquiReason
BLTEBELITE BIO, INCFollow BLTE — free
—
Price chart with a free account
- Market cap
- 5.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Dec 25 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 17.3 | 42.1 | 88.2 | 31.7 | 352.9 | 352.9 | |
| Short-term investments | — | — | — | 113.5 | 139.5 | 139.5 | |
| Current assets | 17.4 | 42.8 | 89.9 | 147.1 | 494.3 | 494.3 | |
| Total assets | 18.3 | 44.3 | 94.6 | 152.1 | 780.6 | 780.6 | |
| Current liabilities | 1.6 | 2.1 | 3.6 | 6.1 | 9.9 | 9.9 | |
| Total liabilities | 1.6 | 2.8 | 4.2 | 6.3 | 10.1 | 10.1 | |
| Shareholders' equity | -15.1 | 41.5 | 90.4 | 145.8 | 770.5 | 770.5 |
USD millions · SEC XBRL
BELITE BIO, INC — questions
- How much cash does BELITE BIO, INC have?
- $352.9M in cash and cash equivalents as of 2025-12-31.
- What are BELITE BIO, INC's total assets?
- $780.6M as of 2025-12-31.
- What is BELITE BIO, INC's shareholders' equity?
- $770.5M as of 2025-12-31.
Every figure on this page comes from BELITE BIO, INC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.